Sponsors
The resolution raises awareness and highlights substantial economic and equity impacts of long COVID that could push future policy action, but it is symbolic and provides no funding—so immediate benefits are limited and expectations or downstream costs may rise.
Patients with long COVID and taxpayers: Congressional findings that long COVID could cost an estimated $3.7 trillion over five years may motivate lawmakers to fund research, care, and supports.
Women, Hispanic/Latine, Black, transgender, and disabled people: Official recognition of disproportionate impacts could steer targeted outreach and equity-focused programs.
People with long COVID and people with disabilities: Designating March as Long COVID Awareness Month may increase public awareness and reduce stigma.
Patients with long COVID: The resolution is nonbinding and provides no funding or new services, so it offers no immediate legal or financial benefits.
People with long COVID and people with disabilities: An awareness designation without funding may raise expectations for support that are not met, causing frustration among those seeking care or benefits.
Taxpayers, middle-class families, and small-business owners: Labeling long COVID as widespread and costly could increase pressure on employers and insurers, potentially leading to higher costs or insurance premiums if policy responses follow.
Based on analysis of 1 section of legislative text.
Introduced March 25, 2026 by Valerie Foushee · Last progress March 25, 2026
Declares that long COVID is a serious, multi-organ illness that can last months to years, affects hundreds of millions worldwide, and creates large health and economic harms in the United States. It records findings about who is disproportionately affected, the lack of a specific treatment, and designates March as "Long COVID Awareness Month," but it does not create new programs, funding, or change laws.